Immune T cells can transfer and boost anti-breast cancer immunity

This proof-of-concept study investigates the immune effects in metastatic breast cancer (MBC) patients after “vaccination” with activated T cells (ATC) armed with anti-CD3 x anti-HER2 bispecific antibody (HER2 BATs) followed by immune consolidation with immune ATC “boost” after high dose chemotherap...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncoimmunology
Asıl Yazarlar: Thakur, Archana, Rathore, Ritesh, Kondadasula, Sri Vidya, Uberti, Joseph P., Ratanatharathorn, Voravit, Lum, Lawrence G.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2018
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6279339/
https://ncbi.nlm.nih.gov/pubmed/30524893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1500672
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller